Get the Stockscreener App
0.6255
3.75%
-0.0244
After Hours:
.59
-0.0355
-5.68%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.6255, with a volume of 13.23M.
It is down -3.75% in the last 24 hours and up +41.42% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.6499
Open:
$0.68
24h Volume:
13.23M
Relative Volume:
1.84
Market Cap:
$43.37M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.9623
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-6.54%
1M Performance:
+41.42%
6M Performance:
-7.29%
1Y Performance:
-48.73%
1-Day Range:
$0.576
$0.6835
1-Week Range:
$0.56
$0.86
52-Week Range:
$0.2522
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.6255 | 62.61M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
Is Reviva Pharmaceuticals Holdings Inc. stock ready for a breakoutPortfolio Update Summary & Low Drawdown Trading Strategies - newser.com
How sentiment analysis helps forecast Reviva Pharmaceuticals Holdings Inc. Equity WarrantEarnings Miss & Expert Verified Movement Alerts - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformation2025 Big Picture & Short-Term High Return Strategies - newser.com
Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options dataBull Run & Technical Confirmation Trade Alerts - newser.com
Market reaction to Reviva Pharmaceuticals Holdings Inc. Equity Warrant’s recent news2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reach all time highs in 2025 - newser.com
Technical analysis overview for Reviva Pharmaceuticals Holdings Inc. stockTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant see short term momentumProfit Target & Accurate Intraday Trading Signals - newser.com
Using economic indicators to assess Reviva Pharmaceuticals Holdings Inc. Equity Warrant potential2025 Performance Recap & Risk Controlled Daily Plans - newser.com
Will Reviva Pharmaceuticals Holdings Inc. price bounce be sustainablePortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Published on: 2025-10-10 08:53:22 - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock reversal real or fakeJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Sector ETF performance correlation with Reviva Pharmaceuticals Holdings Inc.Weekly Profit Recap & Reliable Volume Spike Trade Alerts - newser.com
Can machine learning forecast Reviva Pharmaceuticals Holdings Inc. recoveryJuly 2025 Gainers & Precise Buy Zone Identification - newser.com
Is Reviva Pharmaceuticals Holdings Inc. trending in predictive chart modelsWeekly Trend Recap & Technical Confirmation Alerts - newser.com
Is a relief rally coming for Reviva Pharmaceuticals Holdings Inc. holdersQuarterly Investment Review & Intraday High Probability Alerts - newser.com
How to integrate Reviva Pharmaceuticals Holdings Inc. into portfolio analysis toolsWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
Sentiment analysis tools applied to Reviva Pharmaceuticals Holdings Inc. Equity Warrant - newser.com
Largest borrow rate increases among liquid names - TipRanks
Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock trendline breakdownRisk Management & Reliable Entry Point Trade Alerts - newser.com
Real time pattern detection on Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-10-09 05:04:17 - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Reviva Pharmaceuticals (NASDAQ:RVPH) - MarketBeat
What catalysts could drive Reviva Pharmaceuticals Holdings Inc. stock higherEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners - GlobeNewswire
TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews
Volatility clustering patterns for Reviva Pharmaceuticals Holdings Inc.Risk Management & Free High Accuracy Swing Entry Alerts - newser.com
Full technical analysis of Reviva Pharmaceuticals Holdings Inc. stockPortfolio Value Summary & Expert Approved Momentum Ideas - newser.com
Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. explained2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
What analysts say about Reviva Pharmaceuticals Holdings Inc stockHigh Beta Stocks & Minimal Capital Trading - earlytimes.in
Reviva Pharmaceuticals Amends Bylaws to Ease Quorum - MSN
Is this a good reentry point in Reviva Pharmaceuticals Holdings Inc.2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Should you wait for a breakout in Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Retail & Weekly High Return Opportunities - newser.com
Traders Purchase Large Volume of Call Options on Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World
Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference - GlobeNewswire
Reviva Pharmaceuticals Holdings Inc Equity Warrant Stock Analysis and ForecastRisk Management Strategies & Free Explosive Trading Growth - earlytimes.in
Biotech Stocks Rebound After Hours Amid Broader Sector Tailwinds - Nasdaq
What drives Reviva Pharmaceuticals Holdings Inc stock priceHead and Shoulders Patterns & Big Gains Low Cost - earlytimes.in
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):